| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Jun―13 |
Rational design and high-yield expression of SARS-CoV-2 nucleocapsid antigen for a sensitive and specific in-house ELISA |
Abbas Tazarghi, Mehdi Behrouzikhah, Hamidreza Abbasi, Mohsen Ebrahimi, Alijan Tabarraei, Ahad Yamchi, Hadi Razavi Nikoo |
| 2 |
[GO] |
2025―Jul―28 |
Production of SARS-CoV-2 virus-like particles as a vaccine candidate in stable cell lines through inducible E and M protein expression |
Yu Liu, Zhian Chen, Li Yang, Chunmei Gan, Jieshi Tang, Zhaoyue Zheng, et al. (+4) JingYa Ye, C. Alexander Valencia, Hoi Yee Chow, Biao Dong |
| 3 |
[GO] |
2024―Jun―22 |
Screening of Candida spp. in wastewater in Brazil during COVID-19 pandemic: workflow for monitoring fungal pathogens |
Danielly Corrêa-Moreira, Gisela Lara da Costa, Reginaldo Gonçalves de Lima Neto, Tatiana Pinto, Bruna Salomão, Tulio Machado Fumian, et al. (+6) Camille Ferreira Mannarino, Tatiana Prado, Marize Pereira Miagostovich, Lívia de Souza Ramos, André Luis Souza dos Santos, Manoel Marques Evangelista Oliveira |
| 4 |
[GO] |
2023―Mar―07 |
Comparison of vector elements and process conditions in transient and stable suspension HEK293 platforms using SARS-CoV-2 receptor binding domain as a model protein |
Erica A. Green, Nathaniel K. Hamaker, Kelvin H. Lee |
| 5 |
[GO] |
2021―Mar―12 |
Repurposing novel therapeutic candidate drugs for coronavirus disease-19 based on protein-protein interaction network analysis |
Masoumeh Adhami, Balal Sadeghi, Ali Rezapour, Ali Akbar Haghdoost, Habib MotieGhader |
|
